Tonix Pharmaceuticals Holding Operating Income

Tonix Pharmaceuticals Holding (TNXP) currently reports a operating income of $-170M as of June 2026. That compares with $-82M in the prior-year period — down 100.8% year over year. Use the charts on this page to explore Tonix Pharmaceuticals Holding's operating income history and peer comparisons.

Tonix Pharmaceuticals Holding's operating income decreased from $-82M to $-170M — a 100.8% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Tonix Pharmaceuticals Holding reported $-170M in operating income as of June 2026. That compares with $-82M in the prior-year period — down 100.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-170M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Tonix Pharmaceuticals Holding, and consider following TNXP for alerts when major investors trade the stock.

Tonix Pharmaceuticals Holding is classified in the Healthcare sector. On operating income, it currently shows $-170M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TNXP with unrelated industries.